The FDA has approved a new drug called revumenib that can be taken orally to treat acute leukemia in patients 1 year or older. The drug will be marketed under the brand name Revuforj.

Nvidia helped pulled U.S. stock indexes higher on Tuesday after they stumbled in the morning on worries about escalations in ...

What to know about allegations against Matt Gaetz, new details in the reported testimony hack, and where he stands with ...

President-elect Trump is promising more government efficiency – but is money really being wasted on cats on treadmills?

After months of campaigning and waiting, consumers now know a little more of what they can expect 2025 to bring. A second ...

The Newcells aProximateTM near-physiological kidney transporter model provides cross-species comparison of drug handling.

Astellas Pharma (ALPMY) announced the Food and Drug Administration issued a Complete Response Letter regarding the supplemental new drug ...

Leaders of the new Rutgers School of Medicine (RSOM) have released a new mission, vision and values statement that ...

Tottenham announced they had “remastered” their brand identity. For anyone left confused by that phrase, don’t worry, you ...

Medical professionals have long known that the earlier a disease is detected, the higher the chance for a better patient outcome.

Tonix Pharmaceuticals (TNXP) presented data in a poster presentation at the ACR Convergence 2024 Annual Meeting, held November 14-19, 2024, in ...

Co-founder Carlos Quirarte took Page Six on a tour of the Western-inspired Lower East Side haunt that has continuously ...